F. Hoffmann-La Roche Ltd (manufacturing unpackaged products, packaging, quality control testing, batch release)
UkraineAll drugs from this manufacturer
-
The drug is used to treat adults with metastatic or early breast cancer if the tumor has a specific feature — overexpression of the HER2 protein or amplification of the HER2 gene.
Dosage form: solution for injection
Active substance Dosage trastuzumab 600 mg/5 ml ATC: L01FD01